Search
SOLACI Congress
Presentations

TAVI: dónde estamos y a dónde vamos

solaci
solaci
20
0

4_daniel_berrocal
Daniel Berrocal
2014-12-05

MD, PhD, MTSAC, FACC
Jefe de Cardiología Intervencionista 
Hospital Italiano – Buenos Aires

Previous article
INTERVENCIONES CORONARIAS en PACIENTES con FIBRILACI
Next article
Revascularización Percutánea Coronaria Aplicación de los Ultimos Avances en Latinoamérica
solaci
solaci

More articles by this author

Scaffold bioabsorbibles. Estado Actual y Proyección

solaci - 0
Roberto Botelho2014-12-05MD, PhD

Estado Actual del Cierre Percutáneo de la Orejuela Auricular Izquierda

solaci - 0
Aníbal Damonte 2014-12-05Departamento de Cardiología IntervencionistaInstituto Cardiovascular de RosarioRosario, Argentina

Revascularización Percutánea Coronaria Aplicación de los Ultimos Avances en Latinoamérica

solaci - 0
Hugo Londero2014-12-05Sanatorio Allende – CórdobaAgentina 

Angioplastia de Tronco Coronário Izquierdo: Perspectiva

solaci - 0
Gilberto L. Nunes2014-12-05Hospital Divina Providencia. Porto Alegre, RSBRASIL  

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Presentations

Scaffold bioabsorbibles. Estado Actual y Proyección

Roberto Botelho2014-12-05MD, PhD
solaci -
SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy